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ABSTRACT 
Objectives: To study the incidence of acute viral hepatitis (A, B, 
or C) in Belgium, manifested clinically by patients who consult 
a general practitioner. 
Methods: During 2 successive years (1991 and 1992), 187 
sentinel general practitioners registered all patients for whom 
a clinical suspicion existed of acute viral hepatitis. In addition 
to epidemiologic data, blood samples were taken at the time 
of registration and 3 and 9 months later. 
Results: There were 209 patients registered. Incidence per 
100,000 inhabitants was estimated at 23 for hepatitis A, 6 for 
hepatitis B, and 3 for hepatitis C. 
Conclusions: The incidence of clinical acute viral hepatitis (A, 
B, and C) was dramatically lower in 1991-92 than in the period 
1982-84. The average age of patients with hepatitis A rose 
significantly. 
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Most of the viral hepatitis studies that have been con- 
ducted in Belgium have focused on the seroprevalence 
of hepatitis A (HAV), hepatitis B (HBV), and hepatitis C 
(HCV) markers. Due to improved socioeconomic and 
hygienic living conditions during the last decades, a 
decline in the prevalence of HAV antibodies has been 
observed.’ This decline was confirmed by the 1994 age- 
standardized prevalence study using a representative sam- 
pling of the Flemish population.2 By generalizing the data 
from this study, it was estimated that 5,181,624 patients 
had at one time been infected with HAV; 747,447 patients 
with HBV, of which 70,704 patients were chronic carri- 
ers of the hepatitis B surface antigen (HBsAg); and 87,875 
patients were once infected with HCV These projections 
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of the national rates of viral hepatitis may be underesti- 
mates since they are based on a single geographic region 
of the country. Nevertheless, these figures reveal the sig- 
nificance of viral hepatitis. 
Within the network of sentinel general practitioners, 
the incidence of acute symptomatic viral hepatitis was 
first studied in 1982-84.3,* The figures of the compulsory 
notification of infectious diseases were much lower than 
the estimations made by the network of sentinel general 
practitioners. With the prospect of a generalized vacci- 
nation campaign for HBV and considering the diminish- 
ing fraction of the population that is protected from HAV 
infections due to natural immunity acquired during child- 
hood, it is important to actualize the Belgian incidence 
data on acute viral hepatitis. A detailed report concern- 
ing the incidence of clinical acute viral hepatitis was pub- 
lished in January 1997.5 
The network of sentinel general practitioners has 
been functioning since 1979 and serves as a morbidity 
surveillance system. 6’ Such a surveillance system has 
already been tested and found effective, and is currently 
applied in a number of countries.s-10 It has been ade- 
quately proven that the Belgian sentinel general practices 
form an important source of data concerning a wide 
range of both infectious and noninfectious diseases. 
MATERIAL AND METHODS 
The data from this study were collected from the 187 
sentinel general practitioners who regularly participated 
in the registrations. The network of sentinel practices 
consists of physicians who, with respect to age and sex, 
are representative of general practitioners in Belgium. 
The general practices are distributed evenly over the ter- 
ritory by means of a cluster analysis based on epidemio- 
logic criteria.” The sentinel population was estimated to 
be 138,017 (1.5% of the general population). 
Since only the patients (n = 209) for whom a clinical 
suspicion of acute viral hepatitis was present were regis- 
tered, the incidences obtained relate exclusively to the 
cases of acute viral hepatitis that have manifested them- 
selves clinically Each sentinel physician was free to decide 
what he or she understood “clinical suspicion” to mean. 
At the time of registration, information was taken about 
the sex and birth date of the patient, and a blood sample 
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was requested to be sent for analysis to the reference lab- 
oratory for viral hepatitis. After 3 and 9 months, the sen- 
tinel physician again sent a blood sample to the reference 
laboratory, to follow the patient’s progress. Assessment 
was also done on risk factors and clinical state. 
Radioimmunoassays (RIA) (Sorin Biomedica, Sluggia, 
Italy) were used to test for HAV serology (anti-HAV/IgG 
and IgM). Serology of HBV markers (HBsAg, antibodies 
to HBsAg [anti-HBs], antibodies [lgG and IgM] to the HBV 
core antigen [anti-HBc]) were performed by RIA and IMX 
technology from Abbott Laboratories. The RLA from Sorin 
Biomedica was used to test for HDV (hepatitis D virus) 
serology. Screening for HCV was performed with the fol- 
lowing tests from Abbott Laboratories (Chicago, IL): 
enzyme immunoassay (EIA) technique (second-genera- 
tion HCV EIA) and the IMX and MATRIX apparatus. For 
the hepatitis E virus (HEV), the antibodies (anti-HEW were 
detected with HEV EL4 (Abbott Laboratories). The inter- 
pretation of positive and negative results for all tests was 
carried out as recommended by the test manufacturer. 
The 95% confidence intervals (Cl) were calculated on 
the assumption that the cases followed a Poisson distri- 
bution. EpiInfo 6.02@ and SPSS-PC 6.l@  (SPSS Inc., 
Chicago, IL, USA) were used for analysis, statistical pro- 
cessing, and detection of significant differences. Signiti- 
cant differences were determined with odds ratio (OR) 
and Cornfield 95% CI for OR and with the Yates-corrected 
chi-square (x2,) or with the Fisher’s exact 2-tailed P-value, 
if an expected cell value was smaller than 5. 
RESULTS 
Incidence 
On the basis of clinical data, 209 patients were registered 
in 1991-92 having a suspicion of acute viral hepatitis. 
This means that each year, in 100,000 inhabitants, there 
were 76 patients (55% men and 45% women) with a sus- 
picion of clinical acute viral hepatitis. The serologic analy- 
sis resulted in the following distribution: HAV, 67%; HBV; 
18%; HCV; 10%; HEV, 2%; and 3% of the patients were pos- 
itive for HBV and HCV None of the HBV-positive patients 
appeared to be positive for HDV 
After extrapolation, the annual incidence for acute 
hepatitis A was estimated at 23 cases per 100,000 inhab- 
itants. The youngest hepatitis A patient was less than 1 
year old, and the oldest was 55 years old; 63% of the 
patients were between 20 and 49 years old, and 23% 
were younger than 20 years; 59% were male. The annual 
incidence of acute hepatitis B was estimated at 6 per 
100,000 inhabitants; 73% were male. All patients were 
between 20 and 49 years old; 55% were between 20 and 
29 years old. The annual incidence of acute hepatitis C 
was estimated at 3 per 100,000 inhabitants; 67% were 
male. All patients were between 19 and 78 years old; 
50% were older than 69 years. The two patients who 
were positive for hepatitis B and C were 23 and 24 years 
old; both were male. The patient with hepatitis E was a 
61-year-old female. 
Risk Factors 
For 54% of patients one or more risk factors for hepati- 
tis infection were mentioned; for 24% an iatrogenic expo- 
sure (e.g., surgical intervention, blood transfusion, 
specialized examination or treatments) was a possible 
risk factor. Nonprofessional contact with hepatitis patients 
was mentioned for 22% of the patients. This involved pri- 
marily contacts at school or in sheltered communities. 
For 12% there existed a high-risk sexual behavior (i.e., 
homosexual or multiple heterosexual contacts, including 
prostitution). In the course of the 6 months preceding 
registration, 11% had travelled to high-risk countries. For 
9%, food was a possible source of infection; shellfish was 
the most common suspect food. For 8%, a professional 
risk was mentioned: they worked in hospitals, institu- 
tions, or laboratories. Dentists also belonged to this group. 
Intravenous drug use was found in 4%. A complete 
overview of all registered risk factors by type of hepati- 
tis is shown in Table 1. 
Clinical Manifestations 
At the time of registration, 59% of the patients with HAV 
were jaundiced, 54% of these patients had elevated 
transaminases and 49% had both elevated transaminases 
and jaundice. No patient with HAV was still jaundiced 
after 3 or 9 months. After 3 months, 15% still had ele- 
vated transaminases; after 9 months, no patient had ele- 
vated transaminases. Jaundice occurred in 50% of the 
children younger than 6 years, in 66% of the children 
between 6 and 20 years, and in 58% of the adults with 
HAV In these age groups, elevated transaminases were 
found in 50%, 66%, and 50% of the cases, respectively 
At the time of registration, 91% of the patients with 
HBV were jaundiced and had elevated transaminases. 
After 3 months of follow-up, 9% of these patients were 
jaundiced and had elevated transaminases; after 9 months 
Table 1. Possible Transmission and 
Risk Factors for Acute Viral Hepatitis 
Hepa tifis 
A  
(n=41) (n=B77) (““6) 
Non-professional contact with 
hepatitis patients 
Trips to endemic regions 
Specialized examinations and treatn 
Consumption of infected food 
Professional risks 
Surgical interventions 
Heterosexual risk behavior 
Blood transfusion 
Homosexual risk behavior 
Intravenous drug use 
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of follow-up, no patients were jaundiced or had increased 
transaminases. 
At the time of registration, 33% of the patients with 
HCV were jaundiced and 67% had elevated transaminases 
which persisted in 50% of them after 3 months of fol- 
low-up and in 25% after 9 months of follow-up. Among 
the HCV patients, 33% had both jaundice and elevated 
transaminases at the time of registration. In none of these 
patients did the jaundice persist after 3 and 9 months. 
Among the patients with both HBV and HCV, 50% 
had elevated transaminases and jaundice at the time of 
registration. After 3 months, transaminases returned to 
normal and the patients were no longer jaundiced. 
The patients with HEV never displayed jaundice and 
had elevated transaminases only at the time of registration. 
DISCUSSION 
On the basis of this 1991-92 study of patients seen by 
general practitioners, the annual incidence per 100,000 
inhabitants of clinical acute viral hepatitis confirmed by 
serologic tests was estimated to be: 23 with HAV, 6 with 
HBV, and 3 with HCV These figures relate only to the 
cases of symptomatic acute viral hepatitis (Table 2). 
Table 2 presents a comparison of the number of 
cases in which hepatitis was clinically suspected in 
1991-92 compared to 1982-83.12 There was a major 
decrease in the number of cases of acute viral hepatitis 
for HAV (x2,, = 47.91, P = 0.000, OR = 3.08 [2.19 < OR < 
4.35]),for HBV (x2, = 20.78, P = 0.0001, OR = 3.12 [2.05 
< OR < 7.541) and for HCV (x2Y = 14.26, P = 0.0002, OR 
= 4.56 [1.90 < OR < 11.131). The decline in the inci- 
dence of hepatitis A was also observed in the rest of 
Europe and around the Mediterranean.13 This reduction 
was attributed to improved socioeconomic, sanitary, and 
hygienic conditions. Incidence figures for hepatitis B are 
more difficult to compare, since most of the studies con- 
ducted had been limited to a specific population group. 
An Italian study among children age 0 to 14 years demon- 
strated that the incidence of hepatitis B fell from 9 cases 
per 100,000 inhabitants in 1985 to 1 case per 100,000 
inhabitants in 1990.‘* 
However, the drop in the incidence shown in this 
study cannot permit one to assume that the number of 
Table 2. Evolution of Hepatitis in Belgium 
1982-84 1997-92 
New Cases hcidence New Cases hcidence 
per Year* per 100,000 per Year* per 100,000 
Hepatitis A 7129 72 2326 23 
(*1.054) (1.792-2.971) 
Hepatitis B 2426 25 618 6 
(+356) (360-989) 
Hepatitis C 1470 15 327 3 
(+216) (150-621) 
*95% Cl in parentheses. 
cases of hepatitis spontaneously fell to a negligible num- 
ber due to the improved living conditions. Oscillations in 
the incidence of hepatitis had already been noted earlier 
in the United States.15 The incidence of hepatitis A in the 
United States has peaked around every 10 years. 
The incidence of hepatitis B in the United States 
increased from the end of the 1970s to a peak in 1986, 
after which the incidence again decreased. This drop was 
due more to a modification of sexual behavior as a result 
of the appearance of the human immunodeficiency virus 
(HIV) than to the application of random vaccinations, 
which began in 1982. I6 In Europe in 1991, the number 
of cases of acute hepatitis B was estimated at 160,000 
cases, corresponding to an incidence of 19 cases per 
100,000 inhabitants. The incidence of acute hepatitis B 
was lowest in Western Europe, at 5 cases per 100,000 
inhabitants, in Central Europe, it was estimated at 22 cases 
per 100,000 inhabitants, and in Eastern Europe 92 cases 
per 100,OOO.i’ 
Whereas during the 1980s hepatitis A was regarded 
virtually as a “childhood illness,“18J9 the average age of 
patients with hepatitis A in this study was 32 years among 
men and 20 years among women. A study of data from 
1982-84 demonstrated that 57% of all acute clinical 
hepatitis A infections occurred among patients between 
5 and 19 years, 3,20 but among patients registered in 
1991-92,69% of the hepatitis A cases were between 20 
and 49 years of age, and only 23% were younger than 20 
years (Figure 1). Improved hygienic conditions, reduced 
the number of infections in young people, however, they 
remained susceptible to the hepatitis A virus.2 Increased 
travel to hepatitis A endemic regions by people not 
immune to the virus caused an increase of infections in 
older age groups. 
It should be noted that because increasing numbers 
of children are treated by a pediatrician, general practi- 
tioners are seeing fewer cases of acute viral hepatitis 
among children. Also, hepatitis A among children younger 
than 5 year of age most often occurs asymptomatically. 
All cases of acute hepatitis B occurred in the age group 
from 20 to 49 years, and in the United States most cases 
appeared in the age group between 20 and 39 yearszl 
which is an indication of the sexual transmission of HBV 
Iatrogenic risk factors and nonprofessional contacts 
with other hepatitis patients appear to have been the 
most prevalent reasons for requesting hepatitis tests. Apart 
from these causes, high-risk sexual behavior, travel to coun- 
tries with high endemicity, and the consumption of 
infected food were frequently recurring risk-factors among 
the patients in whom acute viral hepatitis was suspected. 
This is a sign that the clinical suspicion of acute viral 
hepatitis is often based on a suggestive anamnesis. Among 
the patients in whom the hepatitis A virus was confirmed, 
66% could name a possible source of contamination, and 
almost 60% of these mentioned more than one risk. In 
most cases, nonprofessional contacts with hepatitis 
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Figure 1. Age distribution for hepatitis A. 
patients (27%) and iatrogenic sources of infection (24%) 
such as specialized examinations and treatments, surgical 
interventions, or dental treatment, were indicated as risks 
by the sentinel physician. To a lesser degree, reference 
was made to trips to endemic regions (12%) and to the 
consumption of infected food (12%). 
A study performed in the United States in 1989 
reported roughly the same risk factors for hepatitis A:14 
personal contact with a hepatitis patient (26%) trips to 
endemic regions (4%) and the consumption of infected 
food (3%). In addition, the study in the United States men- 
tioned as important risks working in health care institu- 
tions (14%) and intravenous drug use (11%). 
High-risk sexual contacts (both heterosexual and 
homosexual) (35%) and trips to endemic regions (27%) 
were the most prevalent risk factors among hepatitis B 
patients. In the United States, it was found that 41% of the 
patients who were infected with the hepatitis B virus 
engaged in high-risk heterosexual behavior, 14% had 
homosexual contacts, and 12% used intravenous nar- 
cotics.15 In this study, intravenous drug use was found in 
two patients who had a dual infection with hepatitis B 
and C viruses. Apart from sexual contacts, intravenous 
drug use, iatrogenic infection, trips to endemic regions, 
and vertical transmission from mother to neonate,zz in 
recent years-with an eye to a vaccination strategy- 
more attention has been paid to the horizontal trans- 
mission of hepatitis B, such as transmission of infection 
among children at school, 23 infection through domestic 
contacts with HBsAg carriers,13B2* and among relatives of 
mentally handicapped persons residing in an institution.25 
For hepatitis C there exist roughly the same risk fac- 
tors as for hepatitis B, although the risk of vertical trans- 
mission from mother to neonate is disputed.26-30 In this 
study, however, there were too few hepatitis C cases reg- 
istered to draw conclusions about the risk factors. Trans- 
mission of hepatitis E could have occurred through 
drinking infected water in regions such as Northern 
Africa and the Near and Middle East. A hepatitis E patient 
in this study had vacationed at a camping site in France 
and had eaten oysters. 
The occurrence of jaundice with hepatitis A was not 
linked to age, as has been asserted in other European 
studies.13 Elevated transaminases and jaundice were found 
in 91% of the hepatitis B patients. This can be explained 
by the fact that acute hepatitis B is generally asympto- 
matic, so that it is primarily patients with symptoms such 
as jaundice who consulted a doctor. Only 33% of the 
hepatitis C patients were jaundiced, and 67% had ele- 
vated transaminases. 
In Belgium there is a system of compulsory notitica- 
tion of infectious diseases in Flanders and in Wallonia but 
not in the capital, Brussels. Only 12% of all cases of acute 
viral hepatitis estimated by the network of sentinel general 
practitioners were reported to the system of compulsory 
notification (Table 3). Epidemiologic studies in the Mediter- 
ranean countries found that only 20% of all cases of acute 
viral hepatitis were reported to the system.13 
At the time of the registration, there was no obliga- 
tory vaccination for hepatitis in Belgium. Only people at 
risk working in laboratories or hospitals received vacci- 
nation against HBV People travelling to endemic regions 
for HAV were advised to be vaccinated against HAV Only 
3% of the patients in this study were vaccinated for HBV 
The vaccination status against HAV was not asked for. 
None of the patients vaccinated against HBV were infected 
with the HBV virus. Since 1996 it has been recommended 
that all children 12 years of age should receive vaccina- 
tion against HBV, although it is not obligatory 
CONCLUSION 
Based on the data from the sentinel general practitioners 
in Belgium in 1991-92, each year around 3500 patients 
were stricken by an acute viral hepatitis, whereby clini- 
cal symptoms appeared. For clinical acute hepatitis A, B, 
and C, the incidence has fallen significantly compared to 
a similar registration done in 1982-84. 
The average age of the patients newly infected with 
hepatitis A clearly has increased. Hepatitis A can no longer 
be regarded as a “childhood illness,” since more than 75% 
of the patients with a clinical manifestation of hepatitis A 
are older than 20 years. However, because hepatitis A in 
children most often occurs without symptoms, they were 
Table 3. Comparison between Results of Sentinel 
Practitioners and Compulsory Notification 
Cases Reported Estimation 
to Compulsory by Sentinel 
Iv0 tifica tion * Practitioners* 






Hepatitis A  410 4484 9 
Hepatitis B  280 1150 24 
Hepatitis C 29 608 5 
*In 1991 and 1992 together in Flanders and Wallonia; results of Brussels were 
not included because there is no system of compulsory notification of infectious 
diseases in Brussels. 
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not registered in this study Contact with persons who were 
infected with HAV appeared to be the most important risk 
for the patients with acute viral hepatitis A. Iatrogenic infec- 
tion also appeared to be a possible source of exposure for 
a significant number of patients with hepatitis A. 
The patients with hepatitis B often had high-risk sex- 
ual contacts or travelled to endemic regions. Intravenous 
use of narcotics was indicated relatively infrequently 
among the risk factors for hepatitis. The predominant 
clinical manifestations of hepatitis B were jaundice and 
elevated transaminases. This was the case to a lesser 
degree for hepatitis A and C. 
Although the number of new infections has declined 
in recent years due to improved hygiene and living con- 
ditions and through the modification of sexual behavior 
and drug use, a massive vaccination campaign for hepati- 
tis appears indispensable. A vaccination program appears 
to be necessary above all for hepatitis B, given the greater 
chance of chronic@ and the greater mortality. Clearly, 
the focus of hepatitis A prevention efforts cannot remain 
limited to the vaccination of travellers, given the high 
number of cases found among nontravellers and given 
the long period of occupational disability suffered by 
affected patients. 
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